Drug Combo Could Benefit HER2-Positive Breast Cancer Cases
American Association for Cancer Research
The HER2CLIMB-02 trial reveals significant benefits, especially for breast cancer patients with brain metastases
Multiple myeloma patients treated with CAR T-cell therapy showed similar survival outcomes regardless of race or ethnicity